This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: James E. Huckle: Innovator in Pharmaceutical Formulations
Introduction
James E. Huckle is a notable inventor based in Moorpark, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations.
Latest Patents
Huckle holds a patent for Mcl-1 inhibitor formulations. This patent includes solid dispersions comprising AMG 397, methods of preparing the solid dispersion, and pharmaceutical formulations that utilize AMG 397. His work in this area is crucial for advancing treatment options in various medical conditions.
Career Highlights
James E. Huckle is associated with Amgen Inc., a leading biotechnology company. His role at Amgen has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. With a total of 1 patent, he has demonstrated his commitment to innovation and improving healthcare solutions.
Collaborations
Huckle has collaborated with talented individuals such as Tian Wu and Darren Leonard Reid. These partnerships have contributed to the success of his projects and the advancement of their shared goals in pharmaceutical research.
Conclusion
James E. Huckle's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in Mcl-1 inhibitor formulations, highlight the importance of research and collaboration in developing effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile